CNC
$34.94
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.
Recent News
2 Growth Stocks with All-Star Potential and 1 Facing Challenges
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Centene Confronts ACA Membership Slide And Tests AI Driven Cost Controls
Centene CEO Sarah London highlighted a sharp decline in Affordable Care Act marketplace membership at the Barclays Healthcare Conference. The company is dealing with operational pressures tied to reduced Medicaid and ACA enrollments. AI tools are becoming a key part of Centene’s discussions with hospitals over suspected improper reimbursement practices. For investors watching NYSE:CNC, these membership and enrollment pressures come on top of a weak share price backdrop. Centene closed at...
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision
Vera Therapeutics develops biologic therapies for serious immunological diseases, with a pipeline targeting high-burden conditions.
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology to advance precision oncology solutions.
Why Investors Aren’t Fleeing to Safe-Haven Stocks
When investors fret over geopolitical shocks, they usually rotate into safe havens such as consumer staples and healthcare. Less obviously, tech and software stocks have also advanced, while traditional safety plays such as healthcare and packaged food have sold off. By the time hostilities began, those defensive sectors were already crowded—and no longer quite as cheap.